[1]
M. A. KHAN, S. B. SOMWANSHI, K. T. VADITAKE, and K. B. KOTADE, “QBD-DRIVEN DESIGN AND PHARMACOKINETIC PROFILING OF REMOGLIFLOZIN ETABONATE SUSTAINED-RELEASE MATRIX TABLETS FOR DIABETES MANAGEMENT”, Int J App Pharm, vol. 18, no. 1, pp. 389–400, Jan. 2026.